{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:38:43Z","timestamp":1790858323676,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11899-012-0121-6","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T11:14:03Z","timestamp":1333106043000},"page":"125-132","source":"Crossref","is-referenced-by-count":37,"title":["Chronic Myeloid Leukemia Stem Cell Biology"],"prefix":"10.1007","volume":"7","author":[{"given":"Leslie A.","family":"Crews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona H. M.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,31]]},"reference":[{"issue":"2","key":"121_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.stem.2009.01.008","volume":"4","author":"C Jamieson","year":"2009","unstructured":"Jamieson C. The MLLgnant consequences of reverting to an embryonic transcriptional program. Cell Stem Cell. 2009;4(2):97\u20138.","journal-title":"Cell Stem Cell"},{"key":"121_CR2","first-page":"85","volume":"25","author":"PC Nowell","year":"1960","unstructured":"Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25:85\u2013109.","journal-title":"J Natl Cancer Inst"},{"issue":"4760","key":"121_CR3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y Ben-Neriah","year":"1986","unstructured":"Ben-Neriah Y, Daley GQ, Mes-Masson AM, et al. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene. Science. 1986;233(4760):212\u20134.","journal-title":"Science"},{"issue":"6020","key":"121_CR4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985;315(6020):550\u20134.","journal-title":"Nature"},{"issue":"1","key":"121_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","volume":"63","author":"PJ Fialkow","year":"1977","unstructured":"Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage. Am J Med. 1977;63(1):125\u201330.","journal-title":"Am J Med"},{"issue":"7","key":"121_CR6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7):657\u201367.","journal-title":"N Engl J Med"},{"issue":"11","key":"121_CR7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"SG O\u2019Brien","year":"2003","unstructured":"O\u2019Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003;348(11):994\u20131004.","journal-title":"N Engl J Med"},{"issue":"11","key":"121_CR8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"\u2022 Mahon FX, Rea D, Guilhot J, et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2\u00a0years: the prospective, multicentre stop imatinib (STIM) trial. Lancet Oncol. 2010;11(11):1029\u201335. This study highlights the role of therapeutically resistant LSC in progression and relapse of disease in patients with CML.","journal-title":"Lancet Oncol"},{"issue":"11","key":"121_CR9","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","volume":"107","author":"M Copland","year":"2006","unstructured":"Copland M, Hamilton A, Elrick LJ, et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood. 2006;107(11):4532\u20139.","journal-title":"Blood"},{"issue":"1","key":"121_CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99(1):319\u201325.","journal-title":"Blood"},{"issue":"46","key":"121_CR11","doi-asserted-by":"crossref","first-page":"17967","DOI":"10.1073\/pnas.0808303105","volume":"105","author":"Y Minami","year":"2008","unstructured":"Minami Y, Stuart SA, Ikawa T, et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci U S A. 2008;105(46):17967\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"121_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2006.11.047","volume":"128","author":"M Grimmler","year":"2007","unstructured":"Grimmler M, Wang Y, Mund T, et al. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell. 2007;128(2):269\u201380.","journal-title":"Cell"},{"issue":"2","key":"121_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10555-010-9221-8","volume":"29","author":"C Chiodoni","year":"2010","unstructured":"Chiodoni C, Colombo MP, Sangaletti S. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 2010;29(2):295\u2013307.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"121_CR14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.molonc.2010.06.001","volume":"4","author":"MA Essers","year":"2010","unstructured":"Essers MA, Trumpp A. Targeting leukemic stem cells by breaking their dormancy. Mol Oncol. 2010;4(5):443\u201350.","journal-title":"Mol Oncol"},{"issue":"6","key":"121_CR15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood-2009-01-202606","volume":"114","author":"SW Lane","year":"2009","unstructured":"Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood. 2009;114(6):1150\u20137.","journal-title":"Blood"},{"issue":"7290","key":"121_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","volume":"464","author":"MH Raaijmakers","year":"2010","unstructured":"\u2022 Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010;464(7290):852\u20137. This study shows that primary stromal dysfunction due to ablation of the Dicer1 gene can result in secondary neoplastic disease, supporting the concept of niche-induced oncogenesis. This is one of recent seminal studies that underscores the importance of the malignant niche in leukemia development and progression.","journal-title":"Nature"},{"issue":"7308","key":"121_CR17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"\u2022 Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829\u201334. This study defines the partnership between somatic and hematopoietic cells indicative of a unique niche in the bone marrow made of heterotypic stem-cell pairs. This highlights the bidirectional nature of interactions between hematopoietic cells and the cellular components of the surrounding stromal microenvironment.","journal-title":"Nature"},{"issue":"1","key":"121_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","volume":"7","author":"L Jin","year":"2008","unstructured":"Jin L, Tabe Y, Konoplev S, et al. CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol Cancer Ther. 2008;7(1):48\u201358.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"121_CR19","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1073\/pnas.0900189106","volume":"106","author":"AE Abrahamsson","year":"2009","unstructured":"Abrahamsson AE, Geron I, Gotlib J, et al. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proc Natl Acad Sci U S A. 2009;106(10):3925\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"121_CR20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ni1006-1021","volume":"7","author":"JJ Trowbridge","year":"2006","unstructured":"Trowbridge JJ, Moon RT, Bhatia M. Hematopoietic stem cell biology: too much of a Wnt thing. Nat Immunol. 2006;7(10):1021\u20133.","journal-title":"Nat Immunol"},{"issue":"6","key":"121_CR21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","volume":"12","author":"C Zhao","year":"2007","unstructured":"Zhao C, Blum J, Chen A, et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell. 2007;12(6):528\u201341.","journal-title":"Cancer Cell"},{"issue":"1","key":"121_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y Hu","year":"2009","unstructured":"Hu Y, Chen Y, Douglas L, Li S. Beta-catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia. 2009;23(1):109\u201316.","journal-title":"Leukemia"},{"issue":"6835","key":"121_CR23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35077219","volume":"411","author":"J Taipale","year":"2001","unstructured":"Taipale J, Beachy PA. The hedgehog and Wnt signalling pathways in cancer. Nature. 2001;411(6835):349\u201354.","journal-title":"Nature"},{"issue":"5","key":"121_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc796","volume":"2","author":"A Ruiz i Altaba","year":"2002","unstructured":"Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer. 2002;2(5):361\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"121_CR25","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/emboj\/17.13.3505","volume":"17","author":"PW Ingham","year":"1998","unstructured":"Ingham PW. Transducing hedgehog: the story so far. EMBO J. 1998;17(13):3505\u201311.","journal-title":"EMBO J"},{"issue":"38","key":"121_CR26","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.0604568103","volume":"103","author":"JJ Trowbridge","year":"2006","unstructured":"Trowbridge JJ, Scott MP, Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci U S A. 2006;103(38):14134\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"121_CR27","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","volume":"103","author":"JP Radich","year":"2006","unstructured":"Radich JP, Dai H, Mao M, et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2006;103(8):2794\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5933","key":"121_CR28","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324(5933):1457\u201361.","journal-title":"Science"},{"issue":"6886","key":"121_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/417299a","volume":"417","author":"M Duman-Scheel","year":"2002","unstructured":"Duman-Scheel M, Weng L, Xin S, Du W. Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E. Nature. 2002;417(6886):299\u2013304.","journal-title":"Nature"},{"issue":"5","key":"121_CR30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.leu.2404657","volume":"21","author":"A Sengupta","year":"2007","unstructured":"Sengupta A, Banerjee D, Chandra S, et al. Deregulation and cross talk among sonic hedgehog, Wnt, Hox and notch signaling in chronic myeloid leukemia progression. Leukemia. 2007;21(5):949\u201355.","journal-title":"Leukemia"},{"issue":"21","key":"121_CR31","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","volume":"117","author":"H Makishima","year":"2011","unstructured":"Makishima H, Jankowska AM, McDevitt MA, et al. CBL, CBLB, TET2, ASXL1, and IDH1\/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood. 2011;117(21):e198\u2013206.","journal-title":"Blood"},{"issue":"6","key":"121_CR32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1158\/1078-0432.CCR-06-2320","volume":"13","author":"D Perrotti","year":"2007","unstructured":"\u2022 Perrotti D, Neviani P. From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way. Clin Cancer Res. 2007;13(6):1638\u201342. This report provides evidence supporting the utility of targeting aberrant mRNA processing mechanisms in the development of alternative therapies for imatinib-resistant and blast crisis CML.","journal-title":"Clin Cancer Res"},{"issue":"7367","key":"121_CR33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478(7367):64\u20139.","journal-title":"Nature"},{"issue":"15","key":"121_CR34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"\u2022 Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365(15):1384\u201395. This is one of the first studies to identify genetic abnormalities in a component of the cellular splicing machinery that contributes to myeloid abnormalities.","journal-title":"N Engl J Med"},{"issue":"1","key":"121_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng.1045","volume":"44","author":"CN Hahn","year":"2011","unstructured":"Hahn CN, Scott HS. Spliceosome mutations in hematopoietic malignancies. Nat Genet. 2011;44(1):9\u201310.","journal-title":"Nat Genet"},{"issue":"7","key":"121_CR36","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest. 2010;120(7):2254\u201364.","journal-title":"J Clin Invest"},{"issue":"2","key":"121_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","volume":"138","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138(2):271\u201385.","journal-title":"Cell"},{"issue":"5","key":"121_CR38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-010-0615-8","volume":"91","author":"KN Rice","year":"2010","unstructured":"Rice KN, Jamieson CH. Molecular pathways to CML stem cells. Int J Hematol. 2010;91(5):748\u201352.","journal-title":"Int J Hematol"},{"issue":"4","key":"121_CR39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1365-2141.2000.02297.x","volume":"110","author":"S Olivero","year":"2000","unstructured":"Olivero S, Maroc C, Beillard E, et al. Detection of different ikaros isoforms in human leukaemias using real-time quantitative polymerase chain reaction. Br J Haematol. 2000;110(4):826\u201330.","journal-title":"Br J Haematol"},{"issue":"4","key":"121_CR40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12185-009-0286-5","volume":"89","author":"L Vassen","year":"2009","unstructured":"Vassen L, Khandanpour C, Ebeling P, et al. Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia. Int J Hematol. 2009;89(4):422\u201330.","journal-title":"Int J Hematol"},{"issue":"3","key":"121_CR41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.leu.2403616","volume":"19","author":"MW Drummond","year":"2005","unstructured":"Drummond MW, Hoare SF, Monaghan A, et al. Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukemia. 2005;19(3):381\u20139.","journal-title":"Leukemia"},{"issue":"3","key":"121_CR42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1751-553X.2010.01291.x","volume":"33","author":"W Ma","year":"2011","unstructured":"Ma W, Giles F, Zhang X, et al. Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors. Int J Lab Hematol. 2011;33(3):326\u201331.","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"121_CR43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.leu.2403310","volume":"18","author":"S Salesse","year":"2004","unstructured":"Salesse S, Dylla SJ, Verfaillie CM. p210BCR\/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells. Leukemia. 2004;18(4):727\u201333.","journal-title":"Leukemia"},{"key":"121_CR44","doi-asserted-by":"crossref","unstructured":"Bahn JH, Lee JH, Li G, et al. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Res. 2011.","DOI":"10.1101\/gr.124107.111"},{"issue":"7265","key":"121_CR45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nature08489","volume":"461","author":"SP Shah","year":"2009","unstructured":"Shah SP, Morin RD, Khattra J, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009;461(7265):809\u201313.","journal-title":"Nature"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11899-012-0121-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T09:25:34Z","timestamp":1561541134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-012-0121-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,31]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1007\/s11899-012-0121-6","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,31]]}}}